Anzeige
Mehr »
Login
Dienstag, 12.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Wir entschlüsseln die 55 $ pro Aktie Clean-Energy-Chance für SIE!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
157 Leser
Artikel bewerten:
(1)

Methes Energies International Ltd.: African Business Professional Arnold "Kojo" Asante to Join Methes' Management Team

Finanznachrichten News

CELEBRATION, FL / ACCESSWIRE / November 8, 2024 / Methes Energies International Ltd. ("Methes" - http://www.methes.com)/ (OTC PINK:MEIL) is pleased to announce that they have retained Mr. Arnold "Kojo" Asante to the Methes' Management Team, servicing the responsibilities as the company's International Business Commercial & Consumer Office to drive all African b2 biOil initiatives, beginning with the pursuit of multiple opportunities throughout the Economic Communities of Western African States (ECOWAS) and the Southern African Development Community (SADC) as well as the securing registrations and certifications by the region's certification entities, including GSA (Ghana Standard Authorities)

"We have known and worked with Mr. Asante for well over 15 years, beginning with his assignment as our first international distributor for G-OIL®," said Carol Loch, CEO and Chairman of Methes. "His market understanding as well as his business acumen will be a much added addition to our team as we penetrate this hugely potential bio-lubrication marketplace."

Headquartered in Accra, Ghana, Mr. Asante will not only support and execute the initiatives of Methes, but has previously secured b2 product acceptance with the Port Authority and several mining entities. In addition to this, Arnold created a direct to consumer and direct to customer at-home and at-office oil changes and auto services branded as b2 biOil Lubes on Wheels (LOW)…an exciting concept well received by time-starved consumers and customers alike.

"I've been involved in multiple facets of business within the African marketplace;" said Arnold Asante. "I'm very excited to be working again with the founding members of the first certified bio-based motor oil and truly understand the environmental concerns of Africa and looking forward to satisfying these need states."

An assortment of b2 biOils that include passenger car motor oils (0W-20, 5W-20 and 5W-30), heavy duty diesel engine oils (5W-40, 10W-40 and 15W-40), high oleic/high performance hydraulic oils (AW-32, AW-46 and AW-68); and, heavy duty biodegradable gear oils (ISO 220, ISO 320, ISO 460 and ISO 680) has been sent for further testing and certification.

ABOUT

Branded as "b2 biOil," Methes Energies International Ltd., which trades under the symbol "MEIL" on OTC Markets (https://www.otcmarkets.com/stock/MEIL/quote), is a totally green "CLEAN TECH" renewable energy company that manufactures and markets an assortment of biodegradable and bio-based bio-lubricants, by combining domestically sourced farm grown bio-derived feedstocks with proprietary technologies for superior performance, all molded around and supporting the four ideologies of being GREEN: renewable, biodegradable, recyclable and non-toxic (earth-friendly).

# # #

FORWARD LOOKING STATEMENTS
This press release may contain forward-looking statements (Safe Harbor Statements) covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe;" and, similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

CONTACT:
Yale Capital Consulting
813 548-0430
yalecapitalconsulting@outlook.com

SOURCE: Methes Energies International Ltd.



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.